ICAR’s ASF vaccine could de-risk India’s pork supply chain

ICAR has developed and field-validated an indigenous live-attenuated vaccine against African Swine Fever in pigs. With outbreaks associated with near-total mortality and estimated losses of ₹276 crore in Assam and ₹982 crore in Mizoram, it is a biosecurity signal for pork availability, producers and trade.

— Source publishedTue, 4 Aug, 2026, 20:01 IST·First seen Tue, 4 Aug, 2026, 20:03 IST·Source BL · Consumer & Economy

What happened

Indian Council of Agricultural Research (ICAR) · ICAR has developed and field-validated an indigenous live attenuated African Swine Fever vaccine for pigs,

Key facts

  • Pig mortality may approach 100%
  • ₹276 crore estimated losses in Assam during 2020-21 outbreaks
  • 11,382 households affected in Mizoram until 2025
  • ₹982 crore estimated losses in Mizoram

Why this matters

The vaccine opens partnership and distribution opportunities across animal health, cold-chain, pork processing and producer-network platforms seeking to strengthen biosecurity-led supply resilience.

What to watch

  • ICAR technology transfer, commercial production licensing and initial batch volumes.
  • State veterinary department vaccination campaigns, coverage rates and booster or revaccination guidance.
  • ASF incidence, culling orders and pig-movement restrictions in Assam, Mizoram and neighboring states.
  • Evidence of field efficacy across breeds and production systems, including post-vaccination mortality and outbreak recurrence.
  • Availability of DIVA-compatible surveillance protocols and rules for movement of vaccinated pigs.
  • Wholesale pork prices, piglet prices, processor utilization and retailer out-of-stock rates in northeastern markets.
  • FSSAI, interstate animal-health and potential export-market guidance affecting vaccinated pork.
  • Map pork sourcing exposure to Assam, Mizoram, other northeastern production clusters and inter-state live-pig routes.
  • Secure contingent supply agreements with integrated farms, processors and frozen-pork suppliers before vaccination demand tightens available breeding and finishing stock.
  • Track vaccine manufacturing authorization, procurement tenders, state-level deployment plans and per-dose affordability for smallholders.
  • Increase supplier requirements for farm vaccination records, veterinary certification, transport sanitation and outbreak notification.
  • Use expected supply stabilization selectively in regional private-label, processed-meat and foodservice planning rather than assuming immediate national price relief.

Also reported by